MSN Laboratories Pvt. Ltd. urged the Federal Circuit to reconsider a three-judge panel’s January ruling that revived a patent for Novartis AG’s blockbuster heart-disease drug Entresto.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback